日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

The promising potential of camelid nanobodies for nuclear medicine

骆驼科纳米抗体在核医学领域展现出的巨大潜力

期刊:European Journal of Nuclear Medicine and Molecular Imaging
影响因子:7.6
doi:10.1007/s00259-025-07136-y
Biersack, Hans J; Rojas-Fernandez, Alejandro; Ting, Hong-Hoi; Kramer, Vasko; Juweid, Malik E; Mottaghy, Felix M
发表日期：2025
文献求助 收藏

Maleic anhydride derived diphosphines: adaptable chelators for receptor-targeted (99m)Tc, (64)Cu and (188)Re radiotracers

马来酸酐衍生的二膦：适用于受体靶向的 (99m)Tc、(64)Cu 和 (188)Re 放射性示踪剂的可适应性螯合剂

期刊:Chemical Science
影响因子:7.4
doi:10.1039/d5sc02110c
Nuttall, Rachel E; Hungnes, Ingebjørg N; Pham, Truc T; Carter, Oliver W L; Rigby, Alex; Patel, Natasha; Yu, Zilin; Cleaver, Julie; Young, Jennifer D; Cook, Gary J R; Livieratos, Lefteris; Sosabowski, Jane; Ting, Hong Hoi; Vetter, Nicholas; Pringle, Paul G; Ma, Michelle T
信号转导
发表日期：2025
文献求助 收藏

PD-L1 imaging with [(99m)Tc]NM-01 SPECT/CT is associated with metabolic response to pembrolizumab with/without chemotherapy in advanced lung cancer

PD-L1 显像（采用 [(99m)Tc]NM-01 SPECT/CT）与晚期肺癌患者接受帕博利珠单抗联合或不联合化疗后的代谢反应相关

期刊:British Journal of Cancer
影响因子:6.8
doi:10.1038/s41416-025-02991-w
Hughes, Daniel Johnathan; Chand, Gitasha; Johnson, Jessica; Tegala, Ronan; Bailey, Damion; Adamson, Kathryn; Edmonds, Scott; Meszaros, Levente K; Moore, Amelia Elizabeth Broomfield; Manickavasagar, Thubeena; Ndagire, Susan; Gennatas, Spyridon; Georgiou, Alexandros; Ghosh, Sharmistha; Josephs, Debra; Karapanagiotou, Eleni; McLean, Emma; Ting, Hong Hoi; Spicer, James; Goh, Vicky; Cook, Gary J R
肺癌
肿瘤
肿瘤免疫
代谢
PD-L1
发表日期：2025
文献求助 收藏

Correction to: HER2-directed antibodies, affibodies and nanobodies as drug-delivery vehicles in breast cancer with a specific focus on radioimmunotherapy and radioimmunoimaging

更正：HER2靶向抗体、亲和抗体和纳米抗体作为乳腺癌药物递送载体，尤其关注放射免疫疗法和放射免疫成像

期刊:European Journal of Nuclear Medicine and Molecular Imaging
影响因子:7.6
doi:10.1007/s00259-024-06792-w
Altunay, Betül; Morgenroth, Agnieszka; Beheshti, Mohsen; Vogg, Andreas; Wong, Nicholas C L; Ting, Hong Hoi; Biersack, Hans-Jürgen; Stickeler, Elmar; Mottaghy, Felix M
肿瘤
HER2
肿瘤免疫
乳腺癌
免疫/内分泌
发表日期：2024
文献求助 收藏

[(99m)Tc]-labelled anti-Programmed Death-Ligand 1 single-domain antibody SPECT/CT: a novel imaging biomarker for myocardial PD-L1 expression

[(99m)Tc]标记的抗程序性死亡配体1单域抗体SPECT/CT：一种用于心肌PD-L1表达的新型影像学生物标志物

期刊:Ejnmmi Research
影响因子:3
doi:10.1186/s13550-023-00990-7
Nazir, Muhummad Sohaib; Hughes, Daniel Johnathan; Chand, Gitasha; Adamson, Kathryn; Johnson, Jessica; Bailey, Damion; Gibson, Victoria; Ting, Hong Hoi; Lyon, Alexander R; Cook, Gary J R
PD-L1
发表日期：2023
文献求助 收藏

Co-crystallisation and humanisation of an anti-HER2 single-domain antibody as a theranostic tool

抗 HER2 单域抗体的共结晶和人源化作为治疗诊断工具

期刊:PLoS One
影响因子:2.9
doi:10.1371/journal.pone.0288259
Kovilen Sawmynaden, Nicholas Wong, Sarah Davies, Richard Cowan, Richard Brown, David Tang, Maud Henry, David Tickle, David Matthews, Mark Carr, Preeti Bakrania, Hong Hoi Ting, Gareth Hall
HER2
发表日期：2023
文献求助 收藏

HER2-directed antibodies, affibodies and nanobodies as drug-delivery vehicles in breast cancer with a specific focus on radioimmunotherapy and radioimmunoimaging

HER2靶向抗体、亲和抗体和纳米抗体作为乳腺癌药物递送载体，尤其关注放射免疫疗法和放射免疫成像

期刊:European Journal of Nuclear Medicine and Molecular Imaging
影响因子:7.6
doi:10.1007/s00259-020-05094-1
Altunay, Betül; Morgenroth, Agnieszka; Beheshti, Mohsen; Vogg, Andreas; Wong, Nicholas C L; Ting, Hong Hoi; Biersack, Hans-Jürgen; Stickeler, Elmar; Mottaghy, Felix M
肿瘤
HER2
肿瘤免疫
乳腺癌
免疫/内分泌
发表日期：2021
文献求助 收藏

Purified anti-CD3 × anti-HER2 bispecific antibody potentiates cytokine-induced killer cells of poor spontaneous cytotoxicity against breast cancer cells

纯化的抗 CD3 × 抗 HER2 双特异性抗体增强对乳腺癌细胞具有较差自发性细胞毒性的细胞因子诱导的杀伤细胞

期刊:Cell and Bioscience
影响因子:6.1
doi:10.1186/2045-3701-4-70
Qingzhong He, Haisong Zhang, Youzhao Wang, Hong Hoi Ting, Wenhua Yu, Xuetao Cao, Wei Ge
免疫
细胞生物学
乳腺癌
肿瘤细胞
发表日期：2014
文献求助 收藏